Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00599014 · ClinicalTrials.gov registry record
Heart Failure Study: The Atlanta Cardiomyopathy Consortium
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 335
- Enrollment target
NCT00599014: Completed study, sponsored by Emory University.
NCT00599014 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 335 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00599014 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 335 participants
- Enrollment target
Study Summary
Heart failure is a very common cause of hospital admission and there are half a million new cases diagnosed each year in the United States. While some important progress has been made over the last two decades for the treatment of heart failure, there still remains a critical need for further advances in our understanding of this disease in order to significantly improve patient outcomes. Large numbers of heart failure patients need to be studied over time to allow scientists to investigate those factors that influence the responses to therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2007-11 |
| Est. Completion | 2013-06 |
What the finished NCT00599014 record still lists
NCT00599014 is an observational study that tracks outcomes without assigning an intervention. The registered 335 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00599014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00599014 about?
NCT00599014 is a clinical study titled "Heart Failure Study: The Atlanta Cardiomyopathy Consortium". Heart failure is a very common cause of hospital admission and there are half a million new cases diagnosed each year in the United States. While some important progress has been made over the last two decades for the treatment of heart failure, there still remains a critical need for further advanc...
What is the current status of trial NCT00599014?
This trial is currently completed. The enrollment target is 335 participants. The study started on 2007-11. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT00599014?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04134754 · 335 participants · NA
Carbon Dioxide (CO2) Chemosensitivity and SUDEP
- NCT05554406 · 335 participants · Phase 2
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- NCT06183437 · 335 participants · Phase 4
The STOP-MED CTRCD Trial
- NCT06885177 · 335 participants · NA
TECTONIC CAD IVL IDE Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia